Biotechnology Editas Medicine Receives FDA Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Beta Thalassemia April 26, 2022
Biotechnology Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl) April 26, 2022
Biotechnology Here’s How Much You’d Have If You Invested $1000 in Exelixis a Decade Ago April 26, 2022
Biotechnology Blueprint Medicines to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022 April 26, 2022
Biotechnology HALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMA April 26, 2022
Biotechnology Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022 April 26, 2022
Biotechnology Apellis Pharmaceuticals to Host Conference Call on May 4, 2022 to Discuss First Quarter 2022 Financial Results April 26, 2022
Biotechnology BIO-TECHNE INCLUDED ON THE FORBES BEST EMPLOYERS FOR DIVERSITY 2022 LIST April 26, 2022
Biotechnology BioNTech to Report First Quarter 2022 Financial Results and Operational Update on May 9, 2022 April 26, 2022
Search
biotech stock market
